We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
The current BIOX market cap is 873.51M. The company's latest EPS is USD 0.3213 and P/E is 36.82.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 127.58M | 93.19M | -126.4M | 323.19M | 116.59M |
| Operating Income | 16.99M | 2.22M | 12.03M | -3.28M | 5.3M |
| Net Income | 3.91M | -8.43M | 31.99M | -7.3M | -2.68M |
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 160.97M | 173.09M | 209.53M | 334.8M | 416.79M |
| Operating Income | 32.09M | 39.15M | 38.38M | 39.87M | 54.18M |
| Net Income | -16.36M | 4.24M | -3.82M | -3.91M | 20.18M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 785.14M | 872.85M | 845.87M | 818.06M | 819.7M |
| Total Liabilities | 470.39M | 566.24M | 511.6M | 487.56M | 487.07M |
| Total Equity | 314.76M | 306.62M | 334.27M | 330.5M | 332.62M |
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 242.47M | 297.56M | 394.59M | 518.22M | 818.06M |
| Total Liabilities | 180.37M | 236.81M | 304.3M | 359.92M | 487.56M |
| Total Equity | 62.1M | 60.75M | 90.29M | 158.3M | 330.5M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | N/A | 8.83M | N/A | 2.59M | 14.73M |
| Investing | N/A | -19.22M | N/A | -25.73M | -8.69M |
| Financing | N/A | 40.35M | N/A | 32.95M | -26.98M |
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 29.7M | 11.42M | -6.21M | -17.52M | 2.59M |
| Investing | -3.26M | -22.21M | -8.31M | 2.9M | -25.73M |
| Financing | -26.95M | 33.53M | 7.36M | 14.82M | 32.95M |
| Market Cap | 873.51M |
| Price to Earnings Ratio | 36.82 |
| Price to Sales Ratio | 1.78 |
| Price to Cash Ratio | 15.44 |
| Price to Book Ratio | 2.25 |
| Dividend Yield | - |
| Shares Outstanding | 62.8M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 1.22 (8.23%) |
| Company Name | Bioceres Crop Solutions Corp |
| Address |
ocampo 210 bis rosario, santa fe |
| Website | https://biocerescrops.com |
| Industry | blank checks (6770) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
